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Edited by Sandro SonninoAbstract Stargardt disease-3 (STGD3) is a juvenile dominant
macular degeneration caused by mutations in elongase of very
long chain fatty acid-4. All identiﬁed mutations produce a trun-
cated protein which lacks a motif for protein retention in endo-
plasmic reticulum, the site of fatty acid synthesis. In these
studies of Stgd3-knockin mice carrying a human pathogenic
mutation, we examined two potential pathogenic mechanisms:
truncated protein-induced cellular stress and lipid product deﬁ-
ciency. Analysis of mutant retinas detected no cellular stress
but demonstrated selective deﬁciency of C32–C36 acyl phosphat-
idylcholines. We conclude that this deﬁcit leads to the human
STGD3 pathology.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Macular degenerations are a heterogenous group of retinal
disorders that are a major cause of blindness in developed
countries. The most common pathology is age-related macular
degeneration (AMD) which aﬀects approximately 30% of
people over the age of 75. Besides this late form, there are
early-onset hereditary macular pathologies. It is assumed that
understanding their pathogenesis will help design therapies not
only for the juvenile pathologies but also for AMD.
Stargardt disease-3 (STGD3) is a juvenile dominant macular
dystrophy caused by three independent mutations in the gene
which codes for elongase of very long chain fatty acids-4
(ELOVL4) [1–4]. All mutated alleles produce a truncated
ELOVL4 protein that lacks a C-terminal di-lysine motif for
endoplasmic reticulum (ER) retention. Such protein truncation
favors two potential pathogenic mechanisms: (a) deﬁciency of
ELOVL4 lipid products subsequent to reduced ELOVL4 pro-
tein levels in the ER, the site of long chain fatty acid synthesisAbbreviations: AMD, age-related macular degeneration; DHA, doco-
sahexaenoic acid; ELOVL4, elongase of very long chain fatty acid-4;
ER, endoplasmic reticulum; MS, mass spectrometry; m/z, mass-to-
charge ratio; N, nucleotide; PC, phosphatidylcholine; STGD3, Star-
gardt disease-3
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ELOVL4 protein. Experimental data supporting both mecha-
nisms has been obtained from studies of cultured cells which
express an ELOVL4 transgene containing a human STGD3-
pathogenic 5-bp deletion. Contrary to wt ELOVL4, the
mutated protein was shown to leave the ER [5,6] and to upreg-
ulate the cellular levels of BiP (also known as GRP78) and
CHOP (also known as GADD153) [7], two ER chaperon
proteins known to be increased during an unfolded-protein
response.
Recently, we generated an animal model of STGD3, the
Stgd3-knockin mice that carry the human pathogenic 5-bp
deletion in the mouse Elovl4 gene [8]. We have shown that
Stgd3-heterozygous mice reproduce early retinal features of
the human STGD3 pathology: lipofuscin accumulation and re-
duced visual functions [9]. Additionally, Stgd3-homozygous
mice show complete absence of epidermal acylceramides but
normal levels of non-acylceramides [8], a ﬁnding replicated in
several other homozygous Elovl4-mutant mice [10–12]. Unique
to acylceramides are extremely long chain C28–C36 fatty
acids. This suggests that (a) Elovl4 synthesizes C28–C36 fatty
acids and (b) the STGD3 mutations abolish their synthesis and
synthesis of lipids which contain C28–C36 acyl residues.
Retinas have no acylceramides but they do have a unique
group of phosphatidylcholines (PCs) which contain residues
of polyunsaturated C28–C36 fatty acids [13,14]. Therefore,
we hypothesize that the STGD3 mutations reduce the levels
of these PCs in the mouse retina. Such a deﬁcit may play an
important role in the STGD3 pathogenesis since C28–C36 acyl
PCs have been shown to (a) be the only lipid group of photo-
receptor outer segments which contains C28–C36 acyl residues
[13,14], (b) bind strongly to rhodopsin [13], and (c) regulate
activities of photo-transduction proteins [15]. In this study of
mouse retina, we demonstrate not only the presence of C32–
C36 acyl PC deﬁciency but also the absence of an unfolded-
protein response in the retinas of Stgd3-heterozygous mice.2. Materials and methods
2.1. Mice
Stgd3 mice were generated, housed and cared for in accordance with
institutional guidelines as described previously [8].
2.2. Analysis of retinal lipids by mass spectrometry
A pair of mouse retinas was extracted at room temperature for 1 h
using 0.3 ml of a 1:1 (v:v) mixture of chloroform:methanol. Particu-
lates were removed by centrifugation, and the extracted lipids were
analyzed by electrospray mass spectrometry (MS) as described in theEuropean Biochemical Societies.
5460 A. McMahon et al. / FEBS Letters 581 (2007) 5459–5463Supplementary data. For each analyzed lipid sample, a total of ﬁve
consecutive MS sample runs were recorded, and their mean value
was used for quantitative analysis.
2.3. Western blot analysis of BiP protein
Dissected mouse retinas were homogenized and extracted proteins
resolved by sodium dodecyl sulphate–polyacrylamide gel electrophore-
sis. Proteins were transferred to Immobilon-P membranes (Millipore,
Bedford, MA, USA). The membranes were ﬁrst incubated overnight
with phosphate buﬀered saline containing 5% non-fat milk powder
and 0.05% Tween 20, and then for 3 h with rabbit anti-Grp78 (Bip)
antibody (Stressgen, MI, USA), washed and incubated for 1 h with
peroxidase-conjugated goat anti-rabbit IgG secondary antibody (Jack-
son Immunoresearch, West Grove, PA, USA). Washed blots were
developed with the ECL plus Western Blotting Detection System
(Amersham Biosciences, Piscataway, NJ, USA) and exposed to Hyper-
ﬁlm ECL (Amersham Biosciences).
2.4. RT-PCR analysis of XBP1 mRNA
Total RNA was isolated from mouse tissue samples using RNA
Stat-60 (Tel-Test, Friendswood, TX, USA). RT-PCR analysis of
XBP1 mRNAs was performed using the Superscript III Synthesis Sys-
tem (Invitrogen, Carlsbad, CA, USA). The RT reaction was primed
with the XBP1 antisense primer 5 0-AGTTCCTCCAGACTAGCAG-
ACT-3 0 which was subsequently also used to amplify XBP1 sequences.
Sense PCR primers were as follows: 5 0-CTGGAGCAGCAAGTGG-
TGGA-3 0 (primer set #1) and 5 0-GAGAACCACAAACTCCAGCT-Fig. 1. MS analysis of retinal lipids in 5 mM ammonium acetate frAGA-3 0 (set #2). Both primer sets were designed to amplify sequence
encompassing a stress-induced alternatively spliced 29-N sequence of
mouse XBP1 mRNA.
2.5. Nuclease protection assay for Elovl4 mRNAs
Total RNA was extracted and mRNAs were analyzed as described
previously [8].
2.6. Statistical analysis
Data were analyzed for statistical signiﬁcance by a two-tailed, paired
Student’s t-test.3. Results and discussion
3.1. Identiﬁcation of C32–C36 acyl phosphatidylcholines in
mouse retinal extracts
To test the hypothesis that the STGD3 mutation reduces ret-
inal levels of C28–C36 acyl PCs, we performed analysis of
mouse retinal lipids using positive ion mode MS. In this mode,
PC species are easily ionized and analyzed due to the presence
of a positively charged quaternary amine [16]. Since Stgd3-
homozygous mice die within hours of birth, at a time when
their retinas are not developed, the current studies were limitedom (A) a 1-month-old wt and (B) Stgd3-heterozygous mouse.
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morphology and a lifespan comparable to that of wt litter-
mates [8].
MS analysis of retinal lipids generated more than twenty
mass peaks of mass-to-charge ratio (m/z) between 700 and
1100 (Fig. 1). The same major mass peaks are observed in
the retinal samples from wt and Stgd3-heterozygous mice.
Based on m/z value and monoisotopic mass, fourteen peaks
can be assigned to known PC species shown either in Fig. 1
or as follows: 732.6 Da, [PC32:1 + H]+; 758.6 Da, [PC34:2 +
H]+; 782.6 Da, [PC34:0 + H]+; 786.6 Da, [PC36:2 + H]+;
788.6 Da, [PC36:1 + H]+; and 810.6 Da, [PC38:4 + H]+.
In order to conﬁrm the assignments of PC 34:1, PC 44:12,
PC 54:12, PC 56:12 and PC 58:12, their mass peaks were fur-
ther analyzed by tandem MS. When subjected to MS fragmen-
tation, all ﬁve PC species produced only one major fragment
peak (m/z 184.0) (Supplementary data) which corresponds to
positively charged phosphocholine (monoisotopic mass
184.07 Da).
To gain more detailed information on the PC structures, we
further analyzed retinal lipids in the presence of LiCl salt. This
analysis detected the presence of Li-adducts for all PC species
(Supplementary data) seen previously as the protonated PCs
(Fig. 1). Five individual [PC + Li]+ peaks from the MS spectra
were subsequently subjected to tandem MS analysis. Li-ad-
ducts of PCs are more extensively fragmented than are the pro-
tonated PCs, thus yielding more pertinent structural
information [16,17]. Comparison of the acquired m/z values
with the calculated monoisotopic mass of the expected frag-
mentation products (Supplementary data) allowed for a ﬁnal
identiﬁcation of the analyzed lipids as PC species that contain
residues of either: (a) relatively short chain fatty acids (PC
16:0/18:1), or (b) two molecules of docosahexaenoic acid
(DHA) (PC 22:6/22:6), or (c) one C32–C36 fatty acid and
one DHA molecule (PC 32:6/22:6, PC 34:6/22:6 and PC 36:6/
22:6).
In bovine photoreceptor outer segments, the unique C28–
C36 acyl PC species is the only lipid group that contains resi-
dues of such extremely long chain fatty acids [13,14]. Majority
of these fatty acids belong to n3 series with the dominant acyl
chain length of C30–C34 [13]. All identiﬁed retinal C28–C36
fatty acids are polyunsaturated, mostly with six double bonds,
less often with ﬁve or four. On the contrary, C28–C36 acyl
chains of epidermal acylceramides are either saturated or
monounsaturated [8,10–12]. These ﬁndings show that (a)Fig. 2. Absence of an unfolded-protein response in Stgd3 mice. (A) West
heterozygous mice. (B) RT-PCR analysis shows absence of PCR products
mRNA (379 bp and 349 bp for the primer sets #1 and 2, respectively) in th
neonatal Stgd3-homozygous mice. A PCR product derived from the unspliced
respectively) was detected in the skin but not in the retina.Elovl4 elongates fatty acids of all levels of saturation and (b)
a tissue type and its lipid metabolizing proteins determine
which fatty acids are available as substrates for Elovl4-medi-
ated elongation.
3.2. C32–C36 acyl phosphatidylcholines are deﬁcient in the
retinas of Stgd3-heterozygous mice
When the MS spectra of retinal lipids from Stgd3-heterozy-
gous mice are compared with the spectra of their wt litter-
mates, a majority of the corresponding peaks are similar
(Fig. 1). The only peaks that have their heights reduced in
the mutant mouse samples belong to C32–C36 acyl PCs. In or-
der to quantify the decrease, the peak heights of C32–C36 acyl
PCs were normalized to the height of the PC 22:6/22:6 peak
from the same spectrum. Therefore, PC 22:6/22:6 served as
an internal standard with its peak height assigned an arbitrary
unit of 1. Using this approach, we found that the retinal level
of PC 32:6/22:6 was 0.305 ± 0.009 (means ± S.D., n = 5 ani-
mals) in wt and 0.212 ± 0.007 (n = 5) in Stgd3-heterozygous
mice; the PC 34:6/22:6 level was 0.385 ± 0.039 in wt and
0.158 ± 0.012 in mutant mice; and the PC 36:6/22:6 level was
0.101 ± 0.029 in wt and 0.034 ± 0.004 in mutant mice.
In the mutant retinas the levels of PC 32:6/22:6, PC 34:6/22:6
and PC 36:6/22:6 were, therefore, signiﬁcantly reduced
(P < 0.001) down to 69%, 41% and 34% of the wt levels,
respectively. The loss of PC with the longer acyl chain length
(C34:6 or C36:6) was signiﬁcantly greater (P < 0.001) than
the loss of PC containing the shorter C32:6 acyl chain, suggest-
ing that the length of a fatty acid product is determined by the
Elovl4 activity. A similar quantitative outcome was achieved
when comparative analysis of the C32–C36 acyl PC peaks
was performed using mass peaks for lipids other than PC
22:6/22:6 as internal standards.
Retinal PCs were analyzed using positive ion mode which is
less suitable for analysis of other phospholipid species since
they, when ionized, preferentially form negatively charged
ions. Therefore, analysis of mouse retinal lipids was also per-
formed using negative mode MS. As previously reported by
others [13,14], residues of C28–C36 fatty acids were not de-
tected in phosphatidylethanolamines, phosphatidylserines or
phosphatidylinositols. Additionally, our preliminary quantita-
tive analysis of these phospholipids found no signiﬁcant diﬀer-
ences between the wt and mutant retinal lipid samples. These
ﬁndings collaborate with the results of previous epidermal lipid
studies [8,10–12]. They showed that the Elovl4 mutationsern blot analysis of Bip protein in mouse retinas of wt and Stgd3-
derived from the stress-induced, alternatively spliced form of XBP1
e retinas of 3-month-old Stgd3-heterozygous mice and in the skin of
form of XBP1 mRNA (405 bp and 375 bp for the primer sets #1 and 2,
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(acylceramides), but not the levels of lipids that lack these acyl
groups (non-acylceramides).
In summary, the MS analysis of lipids demonstrates that the
STGD3 mutation causes selective deﬁciency of C32–C36 acyl
PCs in mouse retinas. Two previous studies, which analyzed
DHA in diﬀerent STGD3-knockin mouse models, reported
no changes in retinal DHA levels [18,19]. This shows that
the role of exteremely long chain C28–C36 fatty acids in retinal
physiology is independent of that of DHA.
3.3. An unfolded-protein response is not detectable in Stgd3 mice
Pathogenesis of many genetic diseases is associated with
defective folding of a mutant protein which induces an
unfolded-protein response [20]. This protective compensatory
mechanism is characterized by (a) a selective increase in the
expression of a unique group of stress-response proteins, (b)
an overall decrease in the expression of other genes, (c) an
enhanced degradation of cellular proteins, and (d) an induc-
tion of apoptosis if the overload of unfolded proteins is not
resolved.
Here, we present data that are consistent with the conclusion
that an unfolded-protein response is not induced in Stgd3
mice. First of all, the retinal levels of Bip protein, a master reg-
ulator of the cellular stress response [20,21], are not increased
in Stgd3-heterozygous mice relative to their wt littermates
(Fig. 2A). Secondly, neither spliced nor unspliced form of
XBP1 mRNA was detected by RT-PCR analysis in the retinas
of wt and Stgd3-heterozygous mice (Fig. 2B). In the presence
of ER stress, XBP1 is upregulated and its mRNA is alterna-
tively spliced, generating a short form of XBP1 mRNA which
codes for a potent transcriptional activator for many genes of
the unfolded-protein response [20]. XBP1 mRNA was detected
in the epidermis of both neonatal Stgd3-homozygous and wt
mice but only as the unspliced XBP1 mRNA (Fig. 2B). The
latter ﬁndings argue against induction of an unfolded-protein
response in tissues of Stgd3 mice, especially given that the
Stgd3-homozygous mice carry the mutation in both Elovl4 al-Fig. 3. Elovl4 mRNA expression in eyecups from 1-month and 1-year-
old wt and Stgd3-heterozygous mice. S1-nuclease protection assay
detects a 182-N fragment of a 322-N probe protected by wt Elovl4
mRNA, and two fragments (126 Ns and 51 Ns) protected by mutated
Elovl4 (Stgd3) mRNA. The molar amount of Elovl4 mRNA in wt
mouse eyecups is equal to the combined molar amounts of wt and
Stgd3 mRNAs in Stgd3-heterozygous eyecups.leles and express high levels of Stgd3 mRNA in the epidermis
[8].
No decrease in the levels of Elovl4 mRNA expression in
Stgd3-heterozygous retinas (Fig. 3) further supports lack of
an unfolded protein response. The absence of photoreceptor
death in Stgd3-heterozygous retinas [8] is also consistent with
the absence of cellular stress.
3.4. Pathogenic events of, and potential treatments for STGD3
Based on the current and previously published results, we
propose the following pathway of STGD3-pathogenic events:
A. STGD3 mutations result in deletion of the ELOVL4
protein motif for ER retention [1–4].
B. Truncated ELOVL4 protein leaves the ER [5,6] and car-
ries with it associated wt ELOVL4 protein [7,22].
C. Reduced ELOVL4 protein levels in the ER cause
decreased synthesis of ELOVL4 products: C24–C36
fatty acids and lipids containing C28–C36 acyl residues
[8,10–12]. In the retina, this results in C32–C36 acyl
PC deﬁciency (this study).
D. Retinal deﬁcit of C32–C36 acyl PCs changes properties
of photo-transduction proteins [13,15], reducing visual
functions and increasing lipofuscin accumulation as seen
in both STGD3 patients [9] and Stgd3 mice [8].
In animals, a diet rich in n3 fatty acids has been shown to
increase the amounts of retinal polyunsaturated C28–C36 fatty
acids [23] which are synthesized from eicosapentaenoic acid,
but not from DHA [14]. These ﬁndings suggest that the retinal
C28–C36 acyl PC deﬁciency may be corrected by supplementa-
tion with polyunsaturated C28–C36 fatty acids or their precur-
sors. Such treatments have the potential to beneﬁt STGD3
patients (a) by reducing eﬀects of the decreased ELOVL4 syn-
thetic capacity and (b) by compensating for potentially inade-
quate dietary intake of n3 fatty acids.
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